CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Anti-tumor Activity of LYT- 200 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML), or with Relaps...
Phase 1
Louisville, Kentucky, United States and 10 other locations
Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...
Phase 1
Louisville, Kentucky, United States and 43 other locations
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Louisville, Kentucky, United States and 85 other locations
This study will be conducted in two parts. Part 1 will be the Dose Confirmation portion to determine recommended Phase 3 dose (RPTD) of venetoclax in...
Phase 3
Louisville, Kentucky, United States and 160 other locations
VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...
Phase 3
Louisville, Kentucky, United States and 180 other locations
Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid cells (a white blood cell responsible f...
Phase 3
Louisville, Kentucky, United States and 171 other locations
The purpose of the study is to characterize safety and tolerability of cusatuzumab in combination with various therapies used to treat acute ...
Phase 1
Louisville, Kentucky, United States and 22 other locations
drug cusatuzumab added to venetoclax and azacitidine works to treat acute myeloid leukemia (AML) compared to vene...
Phase 2
Louisville, Kentucky, United States and 30 other locations
with intensive chemotherapy in participants with newly diagnosed acute myeloid leukemia (AML) harboring alteratio...
Phase 1
Louisville, Kentucky, United States and 39 other locations
it is safe for participants with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). It will study S...
Phase 1
Louisville, Kentucky, United States and 55 other locations
Clinical trials
Research sites
Resources
Legal